{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:44:00Z","timestamp":1791297840823,"version":"4.1.0"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Osteoblast activity and plasma 1,25(OH)2vitamin D are increased in HPT but suppressed in HHM. To model HPT and HHM, we directly compared multiday continuous infusions of PTH versus PTHrP in humans. Continuous infusion of both PTH and PTHrP results in marked and prolonged suppression of bone formation; renal 1,25(OH)2D synthesis was stimulated effectively by PTH but poorly by PTHrP.<\/jats:p>\n               <jats:p>Introduction: PTH and PTH-related protein (PTHrP) cause primary hyperparathyroidism (HPT) and humoral hypercalcemia of malignancy (HHM), respectively. Whereas HHM and HPT resemble one another in many respects, osteoblastic bone formation and plasma 1,25(OH)2vitamin D are increased in HPT but reduced in HHM.<\/jats:p>\n               <jats:p>Materials and Methods: We performed 2- to 4-day continuous infusions of escalating doses of PTH and PTHrP in 61 healthy young adults, comparing the effects on serum calcium and phosphorus, renal calcium and phosphorus handling, 1,25(OH)2vitamin D, endogenous PTH(1-84) concentrations, and plasma IGF-1 and markers of bone turnover.<\/jats:p>\n               <jats:p>Results: PTH and PTHrP induced comparable effects on renal calcium and phosphorus handling, and both stimulated IGF-1 and bone resorption similarly. Surprisingly, PTH was consistently more calcemic, reflecting a selectively greater increase in renal 1,25(OH)2 vitamin D production by PTH. Equally surprisingly, continuous infusion of both peptides markedly, continuously, and equivalently suppressed bone formation.<\/jats:p>\n               <jats:p>Conclusions: PTHrP and PTH produce markedly different effects on 1,25(OH)2vitamin D homeostasis in humans, leading to different calcemic responses. Moreover, both peptides produce profound suppression of bone formation over multiple days, contrasting with events in HPT, but mimicking HHM. These findings underscore the facts that the mechanisms underlying the anabolic skeletal response to PTH and PTHrP in humans is poorly understood, as are the signal transduction mechanisms that link the renal PTH receptor to 1,25(OH)2vitamin D synthesis. These studies emphasize that much remains to be learned regarding the normal regulation of vitamin D metabolism and bone formation in response to PTH and PTHrP in humans.<\/jats:p>","DOI":"10.1359\/jbmr.050602","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T00:41:38Z","timestamp":1146098498000},"page":"1792-1803","source":"Crossref","is-referenced-by-count":136,"title":["Continuous PTH and PTHrP Infusion Causes Suppression of Bone Formation and Discordant Effects on 1,25(OH)2Vitamin D"],"prefix":"10.1093","volume":"20","author":[{"given":"Mara J","family":"Horwitz","sequence":"first","affiliation":[{"name":"Division of Endocrinology, The University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Tedesco","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, The University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M","family":"Sereika","sequence":"additional","affiliation":[{"name":"University of Pittsburgh School of Nursing and The Graduate School of Public Health, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushtaq A","family":"Syed","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, The University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Garcia-Oca\u00f1a","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, The University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bisello","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, The University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce W","family":"Hollis","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford J","family":"Rosen","sequence":"additional","affiliation":[{"name":"St Joseph's Hospital, Bangor, Maine, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Wysolmerski","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Dann","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caren","family":"Gundberg","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F","family":"Stewart","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, The University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"2024013019254735100_bib1","first-page":"230","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Bilezikian","year":"2003","edition":"5th ed."},{"key":"2024013019254735100_bib2","first-page":"1075","volume-title":"Endocrinology","author":"Silverberg","year":"2001"},{"key":"2024013019254735100_bib3","first-page":"564","volume-title":"Principles and Practice of Endocrinology and Metabolism","author":"Silverberg","year":"2001"},{"key":"2024013019254735100_bib4","first-page":"690","article-title":"Anabolic actions of parathyroid hormone on bone","volume":"14","author":"Dempster","year":"1993","journal-title":"Endocr Rev"},{"key":"2024013019254735100_bib5","first-page":"1562","article-title":"On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism","volume":"84","author":"Dempster","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"2024013019254735100_bib7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)02342-8","article-title":"Randomised clinical trial of the effect of parathyroid hormone on vertebral bone mass and fracture incidence among postmenopausal women with osteoporosis","volume":"350","author":"Lindsay","year":"1997","journal-title":"Lancet"},{"key":"2024013019254735100_bib8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N Engl J Med"},{"key":"2024013019254735100_bib9","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","article-title":"The effects of parathyroid hormone, alendronate or both in men with osteoporosis","volume":"349","author":"Finkelstein","year":"2003","journal-title":"N Engl J Med"},{"key":"2024013019254735100_bib10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMe038143","article-title":"Parathyroid hormone plus alendronate\u2014a combination that does not add up","volume":"349","author":"Khosla","year":"2003","journal-title":"N Engl J Med"},{"key":"2024013019254735100_bib11","first-page":"246","volume-title":"Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Horwitz","year":"2003","edition":"5th ed."},{"key":"2024013019254735100_bib12","first-page":"1093","volume-title":"Endocrinology","author":"Stewart","year":"2001","edition":"4th ed."},{"key":"2024013019254735100_bib13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM198012113032401","article-title":"Biochemical evaluation of patients with cancer-associated hypercalcemia: Evidence for humoral and non-humoral groups","volume":"303","author":"Stewart","year":"1980","journal-title":"N Engl J Med"},{"key":"2024013019254735100_bib14","first-page":"705","article-title":"Nephrogenous cyclic AMP, adenylate cyclase-stimulating activity, and the humoral hypercalcemia of malignancy","volume":"40","author":"Godsall","year":"1986","journal-title":"Rec Prg Horm Res"},{"key":"2024013019254735100_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/jcem-55-2-219","article-title":"Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: Uncoupling of bone cell activity","volume":"55","author":"Stewart","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib16","first-page":"607","article-title":"Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia","volume":"81","author":"Nakayama","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jbmr.5650040115","article-title":"Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancy","volume":"4","author":"Ralston","year":"1989","journal-title":"J Bone Miner Res."},{"key":"2024013019254735100_bib18","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.3685994","article-title":"Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro","volume":"238","author":"Horiuchi","year":"1987","journal-title":"Science"},{"key":"2024013019254735100_bib19","first-page":"E297","article-title":"Effect of parathyroid hormone-like peptides on 25-hydroxyvitamin D-1-\u03b1-hydroxylase activity in rodents","volume":"258","author":"Walker","year":"1990","journal-title":"Am J Physiol"},{"key":"2024013019254735100_bib20","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1210\/endo-124-5-2057","article-title":"Suppression of serum 1,25-dihydroxyvitamin D in humoral hypercalcemia of malignancy is caused by elaboration of a factor that inhibits renal 1,25-dihydroxyvitamin D3 production","volume":"124","author":"Fukumoto","year":"1989","journal-title":"Endocrinology"},{"key":"2024013019254735100_bib21","first-page":"2786","article-title":"Dissociation of bone formation from resorption during two-week treatment with hPTHrP(1-36) in humans: Potential as an anabolic therapy for osteoporosis","volume":"83","author":"Plotkin","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jc.2002-021122","article-title":"Short-term, high-dose PTHrP as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis","volume":"88","author":"Horwitz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib23","first-page":"1052","article-title":"Conditional knockout of PTHrP in osteoblasts leads to premature osteoporosis","volume":"17","author":"Miao","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024013019254735100_bib24","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1210\/en.2003-1695","article-title":"Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice","volume":"145","author":"Miao","year":"2004","journal-title":"Endocrinology"},{"key":"2024013019254735100_bib25","first-page":"1525","article-title":"Parathyroid hormone-related protein (1-36) stimulates renal tubular calcium reabsorption in normal human volunteers: Implications for the pathogenesis of humoral hypercalcemia of malignancy","volume":"86","author":"Syed","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib26","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1210\/jc.2002-020773","article-title":"Direct comparison of sustained infusion of hPTHrP(1-36) versus hPTH(1-34) on serum calcium, plasma 1,25(OH)2 vitamin D concentrations and fractional calcium excretion in healthy human volunteers","volume":"88","author":"Horwitz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-118-5-199303010-00003","article-title":"Estrogen protection against bone-resorbing effects of parathyroid hormone infusion: Assessment by use of biochemical markers","volume":"118","author":"Cosman","year":"1993","journal-title":"Ann Intern Med"},{"key":"2024013019254735100_bib28","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1359\/jbmr.1997.12.6.958","article-title":"Resistance to bone resorbing effects of PTH in black women","volume":"12","author":"Cosman","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024013019254735100_bib29","first-page":"2151","article-title":"Effects of gonadal suppression on the regulation of parathyroid hormone and 1,25-dihydroxyvitamin D secretion in women","volume":"84","author":"Finkelstein","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib30","first-page":"511","article-title":"Lee M-L T, Finkelstein JS. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men","volume":"86","author":"Leder","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib31","first-page":"417","article-title":"A comparison of the in vivo biological responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man","volume":"75","author":"Fraher","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib32","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1172\/JCI113358","article-title":"A synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats","volume":"81","author":"Stewart","year":"1988","journal-title":"J Clin Invest"},{"key":"2024013019254735100_bib33","first-page":"199","article-title":"Parathyroid hormone-related protein(1-36) is equipotent with parathyroid hormone(1-34) in humans","volume":"81","author":"Everhart-Caye","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib34","doi-asserted-by":"crossref","first-page":"10546","DOI":"10.1021\/bi00033a029","article-title":"Probing the bimolecular interactions of parathyroid hormone with the human parathyroid hormone\/parathyroid hormone-related protein receptor. 1. Design, synthesis and characterization of photoreactive benzophenone-containing analogs of parathyroid hormone","volume":"34","author":"Nakamoto","year":"1995","journal-title":"Biochemistry"},{"key":"2024013019254735100_bib35","first-page":"900","article-title":"Parathyroid hormone-related protein(1-36) is biologically active when administered subcutaneously to humans","volume":"82","author":"Henry","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/clinchem\/42.4.586","article-title":"Quantification of circulating 1,25(OH)2D by RIA with an 125-I-labled tracer","volume":"42","author":"Hollis","year":"1996","journal-title":"Clin Chem"},{"key":"2024013019254735100_bib37","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1021\/bi00189a054","article-title":"Parathyroid hormone-related protein: Evidence for transcript- and tissue-specific post-translational processing","volume":"33","author":"Yang","year":"1994","journal-title":"Biochemistry"},{"key":"2024013019254735100_bib38","first-page":"3258","article-title":"Vitamin K status and bone health: An analysis of methods for the determination of \u201cundercarboxylated\u201d osteocalcin","volume":"83","author":"Gundberg","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib39","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1210\/jc.2002-020656","article-title":"IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappa B ligand in vitro and OPG in vivo","volume":"87","author":"Rubin","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib40","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1359\/jbmr.2002.17.9.1570","article-title":"Insulin-like growth factor-1 is required for the anabolic actions of parathyroid hormone on rat bone","volume":"17","author":"Bickle","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024013019254735100_bib41","author":"Yakar"},{"key":"2024013019254735100_bib42","first-page":"377","volume-title":"Principles of Bone Biology","author":"Segre","year":"1996"},{"key":"2024013019254735100_bib43","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1210\/me.2002-0040","article-title":"Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2\u03b1-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts","volume":"17","author":"Ahmed","year":"2003","journal-title":"Mol Endocrinol"},{"key":"2024013019254735100_bib44","doi-asserted-by":"crossref","first-page":"E489","DOI":"10.1152\/ajpendo.2001.281.3.E489","article-title":"Induction of osteoblast differentiation indexes by PTHrP in MG-63 cells involves multiple signaling pathways","volume":"281","author":"Carpio","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024013019254735100_bib45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/endo.141.11.7792","article-title":"Obligate mitogen-activated protein kinase activation in parathyroid hormone stimulation of calcium transport but not calcium signaling","volume":"141","author":"Sneddon","year":"2000","journal-title":"Endocrinology"},{"issue":"S1","key":"2024013019254735100_bib46","first-page":"S338","article-title":"PTH receptor activates wnt\/\u03b2catenin signaling pathway in growth plate chondrocytes ex vivo","volume":"19","author":"Guo","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2024013019254735100_bib47","doi-asserted-by":"crossref","first-page":"43787","DOI":"10.1074\/jbc.M306019200","article-title":"Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50)","volume":"278","author":"Sneddon","year":"2003","journal-title":"J Biol Chem"},{"key":"2024013019254735100_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/8756-3282(88)90001-4","article-title":"Bone and renal components in hypercalcemia of malignancy and response to a single infusion of clodronate","volume":"9","author":"Bonjour","year":"1988","journal-title":"Bone"},{"key":"2024013019254735100_bib49","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200319504","article-title":"Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation","volume":"112","author":"VanHouten","year":"2003","journal-title":"J Clin Invest"},{"key":"2024013019254735100_bib50","first-page":"399","article-title":"Pulsatile secretion of PTH in normal young subjects: A deconvolution analysis","volume":"76","author":"Samuels","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib51","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1172\/JCI117998","article-title":"Time series prediction of parathyroid hormone concentration","volume":"95","author":"Prank","year":"1995","journal-title":"J Clin Invest"},{"key":"2024013019254735100_bib52","first-page":"53","article-title":"Pulse amplitude and frequency modulation of parathyroid hormone in primary hyperparathyroidism","volume":"78","author":"Harms","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019254735100_bib53","doi-asserted-by":"crossref","first-page":"14078","DOI":"10.1074\/jbc.270.23.14078","article-title":"Secretion of parathyroid hormone-related protein: Cell-specific secretion via the regulated vs. the constitutive secretory pathway","volume":"270","author":"Plawner","year":"1995","journal-title":"J Biol Chem"},{"key":"2024013019254735100_bib54","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1172\/JCI119491","article-title":"Parathyroid hormone exerts disparate effects on osteoblastic differentiation depending on the exposure time in rat osteoblastic cells","volume":"99","author":"Ishizuye","year":"1997","journal-title":"J Clin Invest"},{"key":"2024013019254735100_bib55","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/endo.142.9.8356","article-title":"Catabolic effects of continuous PTH(1-38) in vivo is associated with sustained stimulation of RANK-L and inhibition of osteoprotegerin and gene-associated bone formation","volume":"142","author":"Ma","year":"2001","journal-title":"Endocrinology"},{"key":"2024013019254735100_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/8756-3282(90)90073-8","article-title":"Simultaneous assessment of bone resorption and formation in cultures of 22 day fetal rat parietal bones: Effects of parathyroid hormone and prostaglandin E2","volume":"11","author":"Vargas","year":"1990","journal-title":"Bone"},{"key":"2024013019254735100_bib57","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/endo.138.11.5505","article-title":"The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats","volume":"138","author":"Dobnig","year":"1997","journal-title":"Endocrinology"},{"key":"2024013019254735100_bib58","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1210\/endo-125-3-1484","article-title":"Parathyroid hormone stimulates the release of insulin-like growth factor I (IGF-I), IGF-II from neonatal mouse calvariae in organ culture","volume":"125","author":"Linkhart","year":"1989","journal-title":"Endocrinology"},{"key":"2024013019254735100_bib59","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1210\/endo-124-3-1247","article-title":"Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor 1 in osteoblast enriched cultures from fetal rat bone","volume":"124","author":"McCarthy","year":"1989","journal-title":"Endocrinology"},{"key":"2024013019254735100_bib60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1385\/ENDO:12:2:197","article-title":"Growth hormone and aging","volume":"12","author":"Rosen","year":"2000","journal-title":"Endocrine"},{"key":"2024013019254735100_bib61","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199004193221603","article-title":"Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of malignancy","volume":"322","author":"Burtis","year":"1990","journal-title":"N Engl J Med"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2FJBMR.050602","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/20\/10\/1792\/56475450\/5650201009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/20\/10\/1792\/56475450\/5650201009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:09:44Z","timestamp":1710342584000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/20\/10\/1792-1803\/7592871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,1]]},"references-count":61,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[2005,10,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.050602","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,10,1]]},"published":{"date-parts":[[2005,10,1]]}}}